Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$853.0b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$581.2b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$374.3b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

AstraZeneca

Market Cap: UK£236.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Merck

Market Cap: US$304.2b

Operates as a healthcare company worldwide.

Amgen

Market Cap: US$188.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Gilead Sciences

Market Cap: US$175.7b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Vertex Pharmaceuticals

Market Cap: US$113.6b

Operates as a biotechnology company in the United States, Europe, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥14.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Zoetis

Market Cap: US$50.5b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Samsung BiologicsLtd

Market Cap: ₩72.7t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

CSL

Market Cap: AU$66.8b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

WuXi AppTec

Market Cap: CN¥320.7b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Haleon

Market Cap: UK£32.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Alnylam Pharmaceuticals

Market Cap: US$43.4b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Sandoz Group

Market Cap: CHF 28.1b

Develops, manufactures, and markets generic and biosimilars worldwide.

Teva Pharmaceutical Industries

Market Cap: US$35.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Otsuka Holdings

Market Cap: JP¥5.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Daiichi Sankyo Company

Market Cap: JP¥5.1t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Waters

Market Cap: US$31.2b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Hansoh Pharmaceutical Group

Market Cap: HK$234.7b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Natera

Market Cap: US$29.9b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Astellas Pharma

Market Cap: JP¥4.7t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

IQVIA Holdings

Market Cap: US$29.0b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Innovent Biologics

Market Cap: HK$153.6b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$148.5b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Shionogi

Market Cap: JP¥2.9t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Akeso

Market Cap: HK$127.3b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Ipsen

Market Cap: €13.4b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$115.0b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥98.0b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

CSPC Pharmaceutical Group

Market Cap: HK$105.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Orion Oyj

Market Cap: €10.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Elanco Animal Health

Market Cap: US$11.7b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.0b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

WuXi XDC Cayman

Market Cap: HK$79.3b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.